Eli Lilly strengthens cancer portfolio with acquisition of Armo BioSciences and promising immunotherapy asset

Eli Lilly and Company (Lilly), a global leader in the pharmaceutical industry, has taken a significant step toward advancing its cancer treatment pipeline with the ... Read More